SEC Form 4 research
| Issuer | Intellia Therapeutics, Inc. |
|---|---|
| Tickers | NTLA |
| Reporting owners | 56 |
| Officers and directors | 25 |
| Last public filing | 2026-11-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-03 | 2026-11-02 | LEONARD JOHN M | S | 9,000 | $11.99 | Not reported |
| 2026-10-28 | 2026-10-26 | Marantz Jing L. | A | 199,822 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | Marantz Jing L. | A | 275,061 | $0 | Not reported |
| 2026-10-06 | 2026-10-02 | Dube Michael P | S | 1,864 | $12.43 | Not reported |
| 2026-08-24 | 2026-08-21 | LEONARD JOHN M | S | 2,785 | $13 | Not reported |
| 2026-08-24 | 2026-08-20 | LEONARD JOHN M | S | 19,890 | $12.6 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.